Efficacy of Metformin in Lean Women With Polycystic Ovary Syndrome
Status:
Unknown status
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
Insulin resistance is an important feature of the polycystic ovary syndrome,and patiens are
successfully treated with the insulin sensitizing agent metformin. The insulin resistance of
lean patients with the syndrome is debated. In this study, we will study the change in
insulin resistance, metabolic and hormonal factors after 3 months of metformin treatment in
lean PCOS women.